The appointment of a new CEO with a strong background in financial services and tech enterprises is likely to positively impact Renovaro's subsidiary GEDi Cube BV. This strategic move is expected to enhance the development and commercialization of their AI-driven cancer diagnostics, potentially leading to increased investor confidence and a positive short-term impact on RENB's stock price.